Premium
Current standards and pitfalls associated with the transfection of primary fibroblast cells
Author(s) -
Kucharski Mirosław,
Mrowiec Patrycja,
Ocłoń Ewa
Publication year - 2021
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1002/btpr.3152
Subject(s) - transfection , fibroblast , reprogramming , nucleofection , transduction (biophysics) , microbiology and biotechnology , biology , transgene , cell culture , cell , gene , genetics , biochemistry
Cultured fibroblast cells, especially dermal cells, are used for various types of scientific research, particularly within the medical field. Desirable features of the cells include their ease of isolation, rapid cellular growth, and high degree of robustness. Currently, fibroblasts are mainly used to obtain pluripotent cells via a reprogramming process. Dermal fibroblasts, are particularly useful for gene therapies used for promoting wound healing or minimizing skin aging. In recent years, fibroblast transfection efficiencies have significantly improved. In order to introduce molecules (most often DNA or RNA) into cells, viral‐based systems (transduction) or non‐viral methods (transfection) that include physical/mechanical processes or lipid reagents may be used. In this article, we describe critical points that should be considered when selecting a method for transfecting fibroblasts. The most effective methods used for the transfection of fibroblasts include both viral‐based and non‐viral nucleofection systems. These methods result in a high level of transgene expression and are superior in terms of transfection efficacy and viability.